Published in Lab Law Weekly, November 18th, 2005
"Giles and Ashton bring valuable perspective and experience to our company," said Edwin Cohen, founder and chairman of the board of ITI. "We look forward to their guidance as ITI continues to achieve new milestones as an integrated specialty pharmaceutical company developing innovative new nasal drug therapies."
Giles founded Giles & Associates Consultancy, Inc., (GAC) in 2000. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.